Immune-related adverse events during anticancer immunotherapy: Pathogenesis and management

Immunotherapy is one of the most recent systemic treatments to emerge for use in oncology, and is based on the blocking of inhibitory immune checkpoints to potentiate the immune response to cancer. The anti-cytotoxic T lymphocyte-associated antigen-4 antibody ipilimumab and anti-programmed cell deat...

Descripción completa

Detalles Bibliográficos
Autores principales: Stucci, Stefania, Palmirotta, Raffaele, Passarelli, Anna, Silvestris, Erica, Argentiero, Antonella, Lanotte, Laura, Acquafredda, Silvana, Todisco, Annalisa, Silvestris, Franco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5661371/
https://www.ncbi.nlm.nih.gov/pubmed/29113194
http://dx.doi.org/10.3892/ol.2017.6919

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5661371/
https://www.ncbi.nlm.nih.gov/pubmed/29113194
http://dx.doi.org/10.3892/ol.2017.6919

Ejemplares similares